Drug Shortage Report for MYLAN-METFORMIN
Report ID | 5025 |
Drug Identification Number | 02229656 |
Brand name | MYLAN-METFORMIN |
Common or Proper name | METFORMIN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
Strength(s) | 850MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT, 500BT |
ATC code | A10BA |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-07-03 |
Estimated end date | Unknown |
Actual end date | 2018-07-03 |
Shortage status | Resolved |
Updated date | 2018-07-05 |
Company comments | discontinued in ID 53765 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.